Menthol and Mint Experimental Tobacco Marketplace (ETM) Study
The Impact of Menthol and Mint E-liquid Bans on Menthol Cigarette Smokers
1 other identifier
interventional
66
1 country
1
Brief Summary
Menthol cigarettes comprise almost one-third of the United States (US) market share and are disproportionately smoked by racial minorities. Tobacco control policies targeting menthol flavoring in tobacco could have significant public health outcomes, especially among black smokers. One key challenge of tobacco regulation is weighing the risks and benefits of potential policies across different populations (i.e., users and non-users). Tension arises between policies intended to prevent adolescent and young adult (AYA) tobacco initiation and those intended to reduce harm among current tobacco users. The availability of menthol e-liquids may be important for encouraging menthol cigarette smokers to switch to e- cigarettes, but mint e-liquids, which are appealing to AYA, may be unnecessary to facilitate switching. Including mint e-liquids in flavor bans but allowing menthol e-liquids to remain on the market as potential substitution products for menthol smokers may be an optimal policy approach. The study team is proposing a lab study and field assessment to determine how including menthol and mint e-liquids in e-liquid flavor bans or sales restrictions affects tobacco product purchasing and use among menthol cigarette smokers. At lab sessions, participants will complete the Experimental Tobacco Marketplace (ETM) task, a behavioral economics task in which they receive account balances to an online store and can buy menthol cigarettes at escalating costs or buy e-liquids, non-menthol cigarettes, or nicotine replacement gum at fixed costs. They will complete the task under four marketplace conditions: (1) only tobacco e-liquids available, (2) menthol and tobacco e-liquids available, (3) menthol, mint, and tobacco e-liquids available, and (4) tobacco, menthol, mint, fruit, dessert. During a field assessment, product choice is validated by assessing use of products purchased during the ETM task. This proposal will inform policy-makers about the impact banning menthol and mint e-liquids will have on facilitating menthol cigarette smokers switching to e-cigarettes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 13, 2021
CompletedFirst Posted
Study publicly available on registry
May 10, 2021
CompletedStudy Start
First participant enrolled
June 21, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 29, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 29, 2022
CompletedResults Posted
Study results publicly available
June 26, 2024
CompletedJune 26, 2024
April 1, 2022
1.5 years
April 13, 2021
December 22, 2023
June 21, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Total Amount of Combusted Tobacco Purchased
Total amount of non-menthol cigarettes purchased when menthol cigarettes are not available.
Day 3
Total Amount of Combusted Tobacco Purchased
Total amount of non-menthol cigarettes purchased when menthol cigarettes are not available.
Day 4
Total Amount of Combusted Tobacco Purchased
Total amount of non-menthol cigarettes purchased when menthol cigarettes are not available.
Day 5
Total Amount of Combusted Tobacco Purchased
Total amount of non-menthol cigarettes purchased when menthol cigarettes are not available.
Day 6
Secondary Outcomes (1)
Total Amount of E-liquid Purchased
Day 3, Day 4, Day 5, Day 6
Other Outcomes (12)
Total Amount of Non-menthol Cigarettes
Day 3, Day 4, Day 5, Day 6
Total Amount of Tobacco E-liquid Purchased
Day 3, Day 4, Day 5, Day 6
Total Amount of Menthol E-liquid Purchased
Day 3, Day 4, Day 5, Day 6
- +9 more other outcomes
Study Arms (4)
Intervention 1: Fruit, dessert, mint, menthol, tobacco
EXPERIMENTALAll participants receive all interventional e-liquid flavors on separate days.
Intervention 2: Mint, menthol, and tobacco
EXPERIMENTALAll participants receive all interventional e-liquid flavors on separate days.
Intervention 3: Menthol and Tobacco
EXPERIMENTALAll participants receive all interventional e-liquid flavors on separate days.
Intervention 4: Only tobacco
EXPERIMENTALAll participants receive all interventional e-liquid flavors on separate days.
Interventions
Marketplace includes tobacco flavored e-liquids
Marketplace includes menthol and tobacco flavored e-liquids
Marketplace includes mint, menthol and tobacco flavored e-liquids
Marketplace includes fruit, dessert, mint, menthol and tobacco flavored e-liquids
Eligibility Criteria
You may qualify if:
- + years of age
- Self-report smoking at least 5 cigarettes per day for the past year
- Self-report smoking menthol cigarette brands \> 80% of the time
- Breathe carbon monoxide (CO) level \> 8 ppm Willingness to use other tobacco products during the study
- Speak, comprehend, and read English sufficiently to complete study procedures
- Have home access to a computer or tablet with a web camera and internet access
You may not qualify if:
- Currently seeking treatment to quit smoking
- Self-reported serious medical or psychiatric condition(s) including cardiovascular and chronic respiratory diseases
- Body temperature \> 100.4 F
- Cold, flu or Novel Coronavirus (COVID-19) symptoms including fever, cough, and runny nose in the past 30 days
- Currently pregnant, breastfeeding or intending to become pregnant for the duration of the study or unwilling to agree to use adequate protection to avoid pregnancy
- CO reading \> 80 ppm
- Enrollment stratum (Non-Hispanic, white or Black/African American)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Wake Forest Health Sciences
Winston-Salem, North Carolina, 27157, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Limitations and Caveats
Several recruitment methods were utilized to identify participants including flyers, Craigslist and contracting with a clinical research recruitment agency. All methods yielded participants but ultimately were not enough to meet our enrollment goal of 80 participants. We experienced a significant uptick in the number of enrolled participants in the final months of the study. We attribute this to the temporal change that has resulted from a return to normal activities after the COVID-19 pandemic.
Results Point of Contact
- Title
- Emily Harwood
- Organization
- Wake Forest University School of Medicine
Study Officials
- PRINCIPAL INVESTIGATOR
Rachel Denlinger, PhD, MPH
Wake Forest Health Sciences
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 13, 2021
First Posted
May 10, 2021
Study Start
June 21, 2021
Primary Completion
December 29, 2022
Study Completion
December 29, 2022
Last Updated
June 26, 2024
Results First Posted
June 26, 2024
Record last verified: 2022-04
Data Sharing
- IPD Sharing
- Will not share